Clinical Study
Hematopoietic Stem-Cell Transplantation in the Developing World: Experience from a Center in Western India
Table 8
Outcomes of our autologous and allogeneic HSCT patients.
| | Outcomes of our transplant patients | Autologous HSCT ( = 35) | Allogeneic HSCT ( = 15) |
| | Complete remission | 46% (16/35) | 47% (7/15) |
| | Partial remission | 6% (2/35) | 0% (0/15) |
| | Relapse but alive | 8% (3/35) | 13% (2/15) |
| | Transplant related mortality (TRM) | 3% (1/35) | 20% (3/15) |
| | Non-TRM | 37% (13/35) | Causes | 20% (3/15) | Causes | | Disease relapse 9 | | Chronic GVHD 1 | ARDS with multiorgan failure 1 | | Sepsis with multiorgan failure 1 | | Haemorrhagic brain infarction 1 | Haemorrhagic cystitis 1 | | Chronic GVHD 1 | Resistant chronic GVHD 1 |
|
|
